SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001437749-21-017958
Filing Date
2021-07-30
Accepted
2021-07-30 06:02:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A burr20210729_sc13ga.htm SC 13G/A 52249
  Complete submission text file 0001437749-21-017958.txt   53929
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 211129898
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 314 COMMONWEALTH AVENUE #4 BOSTON MA 02115
Business Address 314 COMMONWEALTH AVENUE #4 BOSTON MA 02115 617-410-4770
Burrage Capital Management LLC (Filed by) CIK: 0001796461 (see all company filings)

IRS No.: 272863804
Type: SC 13G/A